Uploaded February 2026 | Updated September 2026, 3 weeks ago

---

Sheila Dodge, Chief Operating Officer at Broad Clinical Labs, shares insights from their progress in scaling Perturb-seq to profile 5 million cells in 5 days with Illumina Single Cell Prep. 

To learn more about the Illumina Single Cell Prep, visit illumina.com/pipseq

For research use only. Not for diagnostic purposes.

Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79

View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ

View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

LinkedIn: linkedin.com/company/illumina
X: https://x.com/illumina
Instagram: instagram.com/illuminainc
Facebook: facebook.com/illuminainc
TikTok: tiktok.com/@illuminainc

#illumina #multiomics #singlecell #scRNA #perturbseq